ENDRA Financial Statements From 2010 to 2025

NDRA Stock  USD 5.10  0.15  2.86%   
ENDRA Life financial statements provide useful quarterly and yearly information to potential ENDRA Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ENDRA Life financial statements helps investors assess ENDRA Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ENDRA Life's valuation are summarized below:
Market Capitalization
2.7 M
Earnings Share
(105.78)
We have found one hundred twenty available fundamental signals for ENDRA Life Sciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of ENDRA Life Sciences prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself in the future.

ENDRA Life Total Revenue

0.0

Check ENDRA Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ENDRA Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 332.6 K, Interest Expense of 23.5 K or Selling General Administrative of 3.7 M, as well as many indicators such as Price To Sales Ratio of 1.8 M, Dividend Yield of 0.0 or PTB Ratio of 6.5 K. ENDRA financial statements analysis is a perfect complement when working with ENDRA Life Valuation or Volatility modules.
  
Check out the analysis of ENDRA Life Correlation against competitors.

ENDRA Life Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.6 M7.8 M4.8 M
Slightly volatile
Other Current Liabilities357.6 K391.4 K271.5 K
Slightly volatile
Total Current Liabilities1.2 MM835.2 K
Slightly volatile
Property Plant And Equipment Net510.7 K535.8 K430.2 K
Slightly volatile
Accounts Payable569.7 K414.5 K388 K
Slightly volatile
Cash4.7 M3.3 M3.2 M
Slightly volatile
Non Current Assets Total4.5 M4.3 M1.1 M
Slightly volatile
Cash And Short Term Investments4.7 M3.3 M3.2 M
Slightly volatile
Common Stock Total Equity4.1 K3.9 K1.6 K
Slightly volatile
Common Stock Shares Outstanding10.9 M10.4 M2.4 M
Slightly volatile
Liabilities And Stockholders Equity6.6 M7.8 M4.8 M
Slightly volatile
Capital Surpluse77.9 M74.2 M36.2 M
Slightly volatile
Inventory3.2 MM939 K
Slightly volatile
Other Current Assets217.3 K228.7 K325.8 K
Slightly volatile
Other Stockholder Equity117.8 M112.2 M45.7 M
Slightly volatile
Total Liabilities1.4 M1.3 M991.7 K
Slightly volatile
Property Plant And Equipment Gross1.3 M1.2 M559.4 K
Slightly volatile
Total Current Assets5.7 M3.5 M3.9 M
Slightly volatile
Common Stock1.3 K1.2 K936
Slightly volatile
Property Plant Equipment510.5 K852.7 K467.2 K
Slightly volatile
Other Liabilities0.80.90.9813
Slightly volatile
Short and Long Term Debt Total452.9 K355 K654.4 K
Slightly volatile
Net Invested Capital7.5 M6.5 M6.2 M
Slightly volatile
Net Working Capital1.8 M1.9 M5.1 M
Pretty Stable
Capital Stock1.9 K1.2 K1.2 K
Slightly volatile
Capital Lease Obligations504.2 K420.8 K431.1 K
Slightly volatile
Preferred Stock Total Equity0.80.90.9813
Slightly volatile
Non Current Liabilities Other245.9 K244.7 K312.9 K
Slightly volatile
Long Term Debt24.4 K25.6 K240.2 K
Slightly volatile
Long Term Debt Total269.7 K303.4 K330.8 K
Slightly volatile

ENDRA Life Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization332.6 K316.8 K125.6 K
Slightly volatile
Selling General Administrative3.7 M5.4 M2.9 M
Slightly volatile
Selling And Marketing Expenses533 K943.6 K409.2 K
Slightly volatile
Other Operating Expenses8.6 M12.1 M6.7 M
Slightly volatile
Research Development4.2 M5.8 M3.3 M
Slightly volatile
Total Operating Expenses8.5 M12.1 M6.6 M
Slightly volatile
Reconciled Depreciation180.8 K324.3 K130.4 K
Slightly volatile
Non Recurring230 K258.8 K282.1 K
Slightly volatile

ENDRA Life Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock13.9 M13.3 M6.6 M
Slightly volatile
Net Borrowings288.2 K303.4 K974.7 K
Slightly volatile
Stock Based Compensation800 K1.1 M595.7 K
Slightly volatile
Begin Period Cash Flow4.4 M5.6 M3.2 M
Slightly volatile
Other Cashflows From Financing Activities1.1 M1.2 M2.1 M
Pretty Stable
Depreciation332.6 K316.8 K132.3 K
Slightly volatile
Capital Expenditures29 K30.5 K128.9 K
Slightly volatile
Total Cash From Financing Activities7.8 M8.6 M5.9 M
Slightly volatile
End Period Cash Flow4.7 M3.3 M3.2 M
Slightly volatile
Change To Netincome1.3 M1.4 M1.2 M
Slightly volatile
Issuance Of Capital Stock8.3 M6.7 M7.6 M
Very volatile
Dividends Paid7187562.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.8 M1.7 M962.6 K
Slightly volatile
Days Sales Outstanding5.696.46.9774
Slightly volatile
Average Payables520 K632.3 K465.6 K
Slightly volatile
Stock Based Compensation To Revenue0.30.250.3043
Slightly volatile
Capex To Depreciation0.130.142.6682
Slightly volatile
EV To Sales1.8 M1.7 M962.1 K
Slightly volatile
Inventory Turnover0.09680.11.3619
Slightly volatile
Days Of Inventory On Hand3.9 K3.7 K1.4 K
Slightly volatile
Payables Turnover0.830.887.8681
Slightly volatile
Sales General And Administrative To Revenue574547299
Slightly volatile
Average Inventory694.5 K1.2 M852.1 K
Slightly volatile
Research And Ddevelopement To Revenue723688376
Slightly volatile
Capex To Revenue15.3114.588.1046
Slightly volatile
Cash Per Share0.340.366.5961
Very volatile
Days Payables Outstanding408430918
Pretty Stable
Income Quality0.590.850.71
Slightly volatile
Current Ratio3.733.024.3678
Pretty Stable
Receivables Turnover41.0646.250.369
Slightly volatile
Graham Number4.334.5547.0654
Very volatile
Capex Per Share0.00410.00430.5353
Slightly volatile
Revenue Per Share0.02990.03151.6844
Slightly volatile
Interest Debt Per Share0.04770.05022.7396
Slightly volatile
Debt To Assets0.06380.06720.8767
Slightly volatile
Operating Cycle3.9 K3.7 K1.4 K
Slightly volatile
Days Of Payables Outstanding408430918
Pretty Stable
Ebt Per Ebit1.311.11.2492
Slightly volatile
Long Term Debt To Capitalization0.00290.0030.0317
Slightly volatile
Total Debt To Capitalization0.07120.07497.4289
Slightly volatile
Quick Ratio3.223.023.335
Slightly volatile
Net Income Per E B T1.161.151.1263
Slightly volatile
Cash Ratio3.02.823.1065
Slightly volatile
Days Of Inventory Outstanding3.9 K3.7 K1.4 K
Slightly volatile
Days Of Sales Outstanding5.696.46.9774
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.141.151.0928
Slightly volatile
Fixed Asset Turnover0.02470.0261.0421
Slightly volatile
Debt Ratio0.06380.06720.8767
Slightly volatile
Price Sales Ratio1.8 M1.7 M962.6 K
Slightly volatile
Asset Turnover9.0E-40.0010.4994
Slightly volatile
Gross Profit Margin0.580.50860.5296
Very volatile

ENDRA Life Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap18.8 B21.1 B23 B
Slightly volatile
Enterprise Value19.4 B13.6 B18.2 B
Slightly volatile

ENDRA Fundamental Market Drivers

Cash And Short Term Investments2.8 M

ENDRA Upcoming Events

12th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About ENDRA Life Financial Statements

ENDRA Life stakeholders use historical fundamental indicators, such as ENDRA Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although ENDRA Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in ENDRA Life's assets and liabilities are reflected in the revenues and expenses on ENDRA Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ENDRA Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue(20.26)(19.25)
Cost Of Revenue247.9 K187.9 K
Stock Based Compensation To Revenue 0.25  0.30 
Sales General And Administrative To Revenue 547.02  574.37 
Research And Ddevelopement To Revenue 688.41  722.83 
Capex To Revenue 14.58  15.31 
Revenue Per Share 0.03  0.03 
Ebit Per Revenue-1.7 K-1.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out the analysis of ENDRA Life Correlation against competitors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(105.78)
Return On Assets
(0.61)
Return On Equity
(1.20)
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.